Page last updated: 2024-11-12

4-hydroxyphenformin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-hydroxyphenformin: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10013772
SCHEMBL ID2739120
SCHEMBL ID17777450
MeSH IDM0088834

Synonyms (13)

Synonym
4-hydroxyphenformin
17426-94-7
1-(diaminomethylidene)-2-[2-(4-hydroxyphenyl)ethyl]guanidine
4-hydroxyphenylethylbiguanide
p-hydroxy-beta-phenethylbiguanide
4-hydroxyphenylethyldiguanide
imidodicarbonimidic diamide, n-(2-(4-hydroxyphenyl)ethyl)-
p-hydroxyphenylethylbiguanide
unii-a1u54nh73s
a1u54nh73s ,
AKOS021356045
SCHEMBL2739120
SCHEMBL17777450

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Of the 141 subjects dosed with debrisoquin, 10 proved to be poor oxidizers, and of the 143 subjects dosed with phenformin, 11 were poor oxidizers."( Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians.
Eichelbaum, M; Idle, JR; Oates, NS; Smith, RL; Woolhouse, NM, 1985
)
0.27
" Although the urinary excretion of unchanged phenformin was greater in PM between 2 and 24 hr after dosing than in EM, excretion of 4-hydroxy-phenformin could not be detected in most samples collected from PM but was present in every sample from EM."( Influence of oxidation polymorphism on phenformin kinetics and dynamics.
Idle, JR; Oates, NS; Shah, RR; Smith, RL, 1983
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]